The Australian Clinical Trials Education Centre (A-CTEC) annual conference in Melbourne convened over 250 clinical research professionals for a focused day of dialogue on the challenges and opportunities shaping the future of clinical trials in Australia. For IgniteData, the event represented a meaningful opportunity to engage with the research community, not simply as a technology provider, but as a long-term partner invested in the growth and sustainability of the sector.
IgniteData COO, Richard Yeatman; VP of Provider Development, Chin Weerappuli; and Director of Provider Development, Matthew Hallmark spent the day engaging with site partners at every stage of their journey: those already collaborating with IgniteData, those just getting started, those scaling up, and those exploring how a global site network could support their growth. These conversations provided a vivid picture of the future of clinical research in Australia.
A Sector on the Verge of Significant Growth
One of the clearest signals to emerge from the day was the scale of what is coming. Clinical trials in Australia are expected to double over the next five years. That is not a distant projection—it is an imminent reality that sites, sponsors, and networks need to be preparing for right now.
The conversations Richard had across the day kept returning to the same set of priorities: investing in training, supporting data manager job satisfaction, and ensuring the right technology infrastructure is in place to scale with confidence. Growth that outruns a site’s operational capacity is not growth at all, and the Australian research community is thinking carefully about how to prepare properly rather than simply react.
The Panel: Electronic Systems Without the Fear Factor
The highlight of the conference for many in the room was the panel session titled Planning for the Increased Use of Electronic Systems in Clinical Trials Without the Fear Factor, brilliantly chaired by Peter MacCallum Cancer Centre’s Chief Medical Officer, Dr. Dishan Herath. Chin Weerappuli represented IgniteData alongside Peter Mac colleague, Helen Stevens; Simone Knab from WA Health; and Trina O’Donnell from Bellberry Limited.
The panel title itself captured something important. For many sites, the shift toward electronic systems in clinical trials carries real anxiety: concerns about implementation complexity, staff capability, regulatory compliance, and whether the technology will actually make their lives easier or simply add a new layer of burden. The panelists addressed these fears head-on, drawing on their combined experience across institutions with very different resourcing models and levels of digital maturity.
Discussion ranged across the nuances of scaling research infrastructure, balancing regulatory compliance with the push toward more agile trial design, and what it truly means to build site networks that reflect diverse patient populations. The conversation was grounded, practical, and clearly resonated with an audience that came ready to engage.
Clinical trials in Australia are expected to double over the next five years. The focus now is on preparing properly, investing in training, and ensuring the right technology is in place to scale confidently.
The Question That Made the Room Light Up
For Chin, the standout moment of the day came during the Q&A portion of the panel. A representative from a local Australian site raised their hand and asked a question that stopped the room: they had already heard of IgniteData, and they wanted to know how to partner with them.
That kind of organic recognition, on the other side of the world from where IgniteData began, speaks to the momentum the company has been building in the Asia Pacific region since its expansion there last year. It was a reminder that the conversations happening in conference rooms like the one in Melbourne are not abstract. They translate into real partnerships, real trials, and real patients getting access to treatments that might otherwise remain out of reach.
A Personal Circle, Closed
For Chin, the significance of standing in Melbourne carried a personal weight that went well beyond the professional. For years, members of his Sri Lankan family have traveled to Australia to seek second opinions and access medical care unavailable closer to home. Bringing IgniteData’s global site network to the region felt, in his words, like a true full-circle moment.
Expanding clinical trial access in the Asia Pacific means more patients in the region will have opportunities to participate in cutting-edge research, and more sites will have the infrastructure and network connections to run those trials effectively. That kind of impact is exactly what drives the work.
What the Day Confirmed
Between Richard’s conversations on the floor and Chin’s time on the panel, A-CTEC confirmed something IgniteData has sensed for a while: the Australian clinical research community is not just open to global partnership, it is actively seeking it. Sites are asking smart questions about technology, infrastructure, and scale. They are thinking carefully about how to deliver better outcomes for patients as the volume of trials grows. And they are looking for partners who understand the complexity of that challenge and can help them meet it.
IgniteData is honored to be part of that conversation, and even more committed to turning those discussions into lasting partnerships across the region.
A big thank you to Director Matthew Hallmark for curating this partnership, and to Marian Lieschke from Peter MacCallum Cancer Centre for the gracious invitation to speak in Melbourne.